Investors / United States / Canaan
Canaan
Venture capital · Stamford, CT, United States · North America
Canaan is an investment firm that has been backing founders for nearly four decades, from fundamental discovery to mass adoption. It partners with companies across therapeutics, deep tech, cybersecurity and AI, and reports having raised $7B over 13 funds with 73 IPOs and 152 M&A exits.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordstherapeuticsdeep techcybersecurityaihealthcarequantum computing
Your fit with Canaan
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCanaan lists 201 checked portfolio companies on its own site and is named in 29 funding rounds, 11 of them as lead. Its most frequent entry is Series A, 54% of the companies with a known first round. Its largest themes are Healthcare & Biotech (21%), AI & Machine Learning (17%) and Fintech (12%). 77% of its companies are based in United States. It invests most often alongside Western Technology Investment, Comcast Ventures and NEA.
Counts come from funding rounds that name Canaan, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Canaan's whole history. Rounds on record name 29 companies; its own site lists 201. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundCanaan does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 29% |
| Series A | 54% |
| Series B | 7% |
| Growth | 11% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 2 | 1 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 0 | 0 |
| '25 | 7 | 2 |
| '26 | 19 | 8 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 99th | 201 companies |
| Recent activity | 98th | 19 rounds in 12 months |
| Early stage | 61th | 29% of entries at pre-seed or seed |
| Evidence | 75th | 9% of companies confirmed by a round |
| Sector focus | 20th | 21% in its largest sector |
| Reach | 98th | 14 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 21% | 15% |
| AI & Machine Learning | 17% | 18% |
| Fintech | 12% | 12% |
| Enterprise Software | 7% | 8% |
| E-commerce & Marketplaces | 7% | 6% |
| Media & Entertainment | 5% | 4% |
| Cybersecurity | 5% | 4% |
| Industrial & Manufacturing | 5% | 7% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Western Technology Investment | 9 |
| Comcast Ventures | 8 |
| NEA | 7 |
| Accel | 6 |
| Capitoria | 6 |
| Kleiner Perkins | 6 |
| Evolution VC Partners | 5 |
| Initialized | 5 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers18492%
- No longer answers00%
- Points to another company178%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Western Technology Investment
Compare Canaan head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Canaan| Date | Company | Stage |
|---|---|---|
| 11 Nov 2026 | Series A Led | |
| 30 Oct 2026 | Series A | |
| 27 Oct 2026 | Series A | |
| 9 Sept 2026 | Series A | |
| 3 Aug 2026 | Seed | |
| 28 Jul 2026 | Series A Led | |
| 17 Jun 2026 | Series A Led | |
| 16 Jun 2026 | Seed |
Round details for Canaan
Amounts, full round histories and every co-investor in Canaan's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
201 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company develops therapeutic devices for use during surgical procedures. | Healthcare & Biotech | Portfolio page | ||
| Aceiss protects against cyber attacks by revealing unauthorized use of employee access to company systems. | Cybersecurity | Portfolio page | ||
| Acesion Pharma aims to develop more efficacious and safe drugs for the treatment of atrial fibrillation, the most common type of cardiac arrhythmia. | Healthcare & Biotech | Portfolio page | ||
| Actio Biosciences is involved in clinical trials for therapies, including for KCNT1-Related Epilepsy. | Healthcare & Biotech | Jun 2025Series B | Page + round | |
| The company provides community and event management software | EducationReal Estate & Construction | Portfolio page | ||
| Actualyze AI provides an enterprise AI governance platform and AI gateway for companies to manage and secure their AI usage | AI & Machine LearningCybersecurity | Aug 2026Seed | Page + round | |
| Aer Therapeutics develops a therapy to liquify mucus plugs in the lungs to improve lung health | Healthcare & Biotech | Portfolio page | ||
| Aeva develops and produces sensing and perception systems using unique FMCW technology for various applications, including autonomous navigation and industrial production programs. | Industrial & ManufacturingConsumer | Portfolio page | ||
| Agomab is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for fibro-inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| Aireye delivers cutting-edge security for all IT and OT assets, individually protecting each Wi-Fi-enabled asset without isolating them from the network. | CybersecurityAI & Machine Learning | Portfolio page | ||
| Alkymi unlocks investment data from unstructured documents and transforms it into standardized datasets using AI-powered data workflows | FintechAI & Machine Learning | Aug 2025Debt | Page + round | |
| Alterome Therapeutics is a clinical-stage precision oncology company that develops therapies for cancer treatments. | Healthcare & Biotech | Portfolio page | ||
| Altimate AI provides an AI data engineering agent platform to optimize workloads, build data pipelines, migrate workloads, and build data apps | AI & Machine LearningEnterprise Software | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. | Healthcare & Biotech | Portfolio page | ||
| Antiva Biosciences is developing a novel topical therapeutic for the treatment of oncogenic human papillomavirus infections and pre-cancerous cervical lesions | Healthcare & Biotech | Portfolio page | ||
| The company provides an online platform for finding and renting apartments. | Real Estate & Construction | Portfolio page | ||
| Apex.AI develops and provides software and AI solutions for autonomy and mobility | Industrial & ManufacturingMobility & Logistics | Portfolio page | ||
| Apisec provides AI application security testing and exploit validation services | CybersecurityAI & Machine Learning | Portfolio page | ||
| Appsmith builds custom applications more quickly and securely with open-source low-code development | Enterprise SoftwareAI & Machine Learning | Oct 2021Series A | Page + round |
About this data
site last read 10 Nov 2026- Site
- canaan.com
- Last read
- 10 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 20 May 2021
- Companies checked
- 201
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Canaan's profile as data
Pull Canaan's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/canaan.com
# also
GET /v1/firms/canaan.com/portfolio
GET /v1/firms/canaan.com/coinvestors
GET /v1/firms/canaan.com/news